Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 29/5/2020
SIETES contiene 93013 citas

 1 a 20 de 149 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Becker WC, Fiellin DA. Abuse-deterrent opioid formulations - Putting the potential benefits into perspective. N Engl J Med 2017;376:2103-5. [Ref.ID 101625]
2. Cita con resumen
Spielmans GI, Kirsch I. Drug approval and drug effectiveness. Annual Review of Clinical Psychology 2014;214:741-66. [Ref.ID 97582]
3. Cita con resumen
Adler JN, Colbert JA. Medicinal use of marijuana - Polling results. N Engl J Med 2013;368:e30. [Ref.ID 95553]
4.Tiene citas relacionadas
Drazen JM. Believe the data. N Engl J Med 2012;367:1152-3. [Ref.ID 93773]
5.Tiene citas relacionadas Cita con resumen
Kesselheim AS, Robertson CT, Myers JA, Rose SL, Gillet V, Ross KM, Glynn RJ, Joffe S, Avorn J. A randomized study of how physicians interpret research funding disclosures. N Engl J Med 2012;367:1119-27. [Ref.ID 93771]
6.Tiene citas relacionadas Cita con resumen
Herzig S, Rothberg M. Drug prophylaxis in general medical patients: does usage reflect the benefits and risks?. BMJ 2012;344:21-3. [Ref.ID 93191]
7. Cita con resumen
Rahmner PB, Eiermann B, Korkmaz S, Gustafsson LL, Gurvén M, Maxwell S, Eichle H-G, Vég A. Physicians' reported needs of drug information at point of care in Sweden. Br J Clin Pharmacol 2012;73:115-25. [Ref.ID 92249]
8. Cita con resumen
Anónimo. Side effects have women stopping aromatase inhibitors early. DIA Daily 2011:12 de diciembre. [Ref.ID 91681]
9. Cita con resumen
Buiting HM, Rurup ML, Wijsbek H, van Zuylen L, den Hartogh G. Understanding provision of chemotherapy to patients with end stage cancer: qualitative interview study. BMJ 2011;342:857. [Ref.ID 90411]
10. Cita con resumen
Anónimo. Resultados clínicos de medicamentos de marca frente a genéricos: una revisión actualizada a 28/02/11. Boletín Terapéutico Extremeño 2011;2:1-8. [Ref.ID 90001]
11.Tiene citas relacionadas Cita con resumen
Licurse A, Barber E, Joffe S, Gross C. The impact of disclosing financial ties in research and clinical care. A systematic review. Arch Intern Med 2010;170:675-82. [Ref.ID 88423]
12.Tiene citas relacionadas Cita con resumen
Campbell EG. Public disclosure of conflicts of interest. Moving the policy debate forward. Arch Intern Med 2010;170:667. [Ref.ID 88421]
13. Cita con resumen
Tichelaar J, Richir MC, Avis HJ, Scholten HJ, Antonini NF, de Vries TPGM. Do medical students copy the drug treatment choices of their teachers or do they think for themselves?. Eur J Clin Pharmacol 2010;66:407-12. [Ref.ID 88244]
15. Cita con resumen
Basch E. The missing voice of patients in drug-safety reporting. N Engl J Med 2010;362:865-9. [Ref.ID 87995]
16. Cita con resumen
Cook S. H1N1 vaccination begins in UK as English cases rise by 27 000. BMJ 2009;339:940. [Ref.ID 86986]
18.Tiene citas relacionadas
O'Byrne PM. Long-acting beta-agonists in asthma. The editorialists reply. N Engl J Med 2009;361:209. [Ref.ID 86177]
19.Tiene citas relacionadas
Kramer JM. Long-acting beta-agonists in asthma. The author replies. N Engl J Med 2009;361:209. [Ref.ID 86176]
20.Tiene citas relacionadas
Knobil K. Long-acting beta-agonists in asthma. N Engl J Med 2009;361:208-9. [Ref.ID 86175]
Seleccionar todas
 1 a 20 de 149 siguiente >>